Want to join the conversation?
$PFG 2Q15 Q&A: Ryan Krueger from KBW asks Terry to give a bit more detail on the expected amount of AXA closing cost. Terry answers; we are going to have savings from the preferred share cost as well, so we think that run rate will be about the same in the 3Q15 as it has been in the past. We haven’t really called out any AXA acquisition cost per se
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.